Stacker on MSN
New anxiety medications are in the pipeline for 2026
LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...
Monoamine oxidase inhibitors were linked to the highest risk for cardiovascular Standardized MedDRA Queries. Dopamine reuptake inhibition and binding inhibition are linked to antidepressant-related ...
Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...
A meta-analysis of relevant research shows that treatment with a serotonin reuptake inhibitor (SSRI) is associated with an increased risk for brain hemorrhage but that the absolute risk is low.
Beta-blockers such as propranolol have sometimes been blamed for being associated with depression. The authors note that pindolol is a partial antagonist of beta-adrenoreceptors and serotonin 5-HT1A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results